MedKoo Cat#: 565751 | Name: CP4d inhibitor

Description:

WARNING: This product is for research use only, not for human or veterinary use.

CP4d is a novel reversible tg2 transamidase site-specific inhibitor

Chemical Structure

CP4d inhibitor
CP4d inhibitor
CAS#1082605-61-5

Theoretical Analysis

MedKoo Cat#: 565751

Name: CP4d inhibitor

CAS#: 1082605-61-5

Chemical Formula: C18H13N5O5

Exact Mass: 379.0917

Molecular Weight: 379.33

Elemental Analysis: C, 56.99; H, 3.45; N, 18.46; O, 21.09

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
CP4d; CP4 4; CP4-4
IUPAC/Chemical Name
(E)-1-[1-(4-Nitrobenzyl)-1H-1,2,3-triazol-4-yl]-3-(4-nitrophenyl)prop-2-en-1-one
InChi Key
CVKOJPBBOPIMAL-BJMVGYQFSA-N
InChi Code
InChI=1S/C18H13N5O5/c24-18(10-5-13-1-6-15(7-2-13)22(25)26)17-12-21(20-19-17)11-14-3-8-16(9-4-14)23(27)28/h1-10,12H,11H2/b10-5+
SMILES Code
O=[N+]([O-])C1=CC=C(C=C1)/C=C/C(C2=CN(N=N2)CC3=CC=C(C=C3)[N+]([O-])=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 379.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Apperley KYP, Roy I, Saucier V, Brunet-Filion N, Piscopo SP, Pardin C, De Francesco É, Hao C, Keillor JW. Development of new scaffolds as reversible tissue transglutaminase inhibitors, with improved potency or resistance to glutathione addition. Medchemcomm. 2016 Dec 5;8(2):338-345. doi: 10.1039/c6md00565a. eCollection 2017 Feb 1. PubMed PMID: 30108749; PubMed Central PMCID: PMC6072418. 2: Caron NS, Munsie LN, Keillor JW, Truant R. Using FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cells. PLoS One. 2012;7(8):e44159. doi: 10.1371/journal.pone.0044159. Epub 2012 Aug 31. PubMed PMID: 22952912; PubMed Central PMCID: PMC3432096. 3: Colak G, Keillor JW, Johnson GV. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation. PLoS One. 2011 Jan 31;6(1):e16665. doi: 10.1371/journal.pone.0016665. PubMed PMID: 21304968; PubMed Central PMCID: PMC3031627. 4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444990/ 5. Synthesis see: Pardin C, Roy I, Lubell WD, Keillor JW. Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase. Chem Biol Drug Des. 2008;72:189–196. [PubMed] [Google Scholar]